Literature DB >> 9585818

Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: demyelination and fast axonal transport changes in disease.

J K O'Neill1, D Baker, M M Morris, S E Gschmeissner, H G Jenkins, A M Butt, S L Kirvell, S Amor.   

Abstract

The encephalitogenicity of optic nerve tissue was demonstrated in Biozzi ABH (H-2(dq1)) mice. Acute experimental allergic encephalomyelitis (EAE) occurred in 11/14 animals and 4/5 exhibited relapse. The involvement of the optic nerve in spinal cord homogenate induced chronic relapsing EAE (CREAE) was demonstrated by mononuclear cell infiltration and myelin degradation in the optic nerve prior to and during clinical disease. During the relapse phase gross pathological assessment revealed swollen and translucent plaques on the optic nerves. Advanced lesions showed widespread demyelination, astrocytic gliosis and fibrotic changes of the blood vessels. Physiologically, the fast axonal transport of proteins from the retina to the optic nerve and superior colliculus was significantly decreased during relapse. The association of inflammation and demyelination with physiological deficit in the optic nerve highlights the usefulness of this model in the study of multiple sclerosis in which acute monosymptomatic unilateral optic neuritis is a common manifestation. Furthermore, the novel induction of CREAE with optic nerve homogenate suggests that optic neuritis is a common significant role in the pathophysiology and progression of neurological disease in CREAE which may be relevant to studies of optic neuritis in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585818     DOI: 10.1016/s0165-5728(97)00203-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats.

Authors:  Giulia D'Intino; Michela Paradisi; Mercedes Fernandez; Alessandro Giuliani; Luigi Aloe; Luciana Giardino; Laura Calzà
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

2.  Mice devoid of Tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.

Authors:  Jason G Weinger; Peter Davies; Christopher M Acker; Celia F Brosnan; Vladislav Tsiperson; Ashrei Bayewitz; Bridget Shafit-Zagardo
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

Review 3.  Differentiation of multiple sclerosis subtypes: implications for treatment.

Authors:  Andreas Bitsch; Wolfgang Brück
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Immunopathology of the optic nerve in multiple sclerosis.

Authors:  Laura Fernández Blanco; Manuel Marzin; Alida Leistra; Paul van der Valk; Erik Nutma; Sandra Amor
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

5.  Axonal transport rate decreased at the onset of optic neuritis in EAE mice.

Authors:  Tsen-Hsuan Lin; Joong Hee Kim; Carlos Perez-Torres; Chia-Wen Chiang; Kathryn Trinkaus; Anne H Cross; Sheng-Kwei Song
Journal:  Neuroimage       Date:  2014-06-14       Impact factor: 6.556

6.  Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.

Authors:  Sheryl L Herrera; Vanessa L Palmer; Heather Whittaker; Blair Cardigan Smith; Annie Kim; Angela E Schellenberg; Jonathan D Thiessen; Richard Buist; Marc R Del Bigio; Melanie Martin
Journal:  Magn Reson Insights       Date:  2014-11-09

7.  Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

Authors:  Estelle Bettelli; Maria Pagany; Howard L Weiner; Christopher Linington; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

8.  Neuroprotection in a novel mouse model of multiple sclerosis.

Authors:  Katie Lidster; Samuel J Jackson; Zubair Ahmed; Peter Munro; Pete Coffey; Gavin Giovannoni; Mark D Baker; David Baker
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.